Background
Systemic Lupus Erythematosis (SLE) is the prototype of the autoimmune diseases affecting predominantly women in the ratio 9:1. SLE was first described in 1828 1 .It is characterised by a multisystem organ involvement because of deregulation of self reactive B cells leading to autoantibody production, immune complex deposition and complement activation with tissue damage. It is important for physicians to be aware of the consequences of the disease and to improve the patient quality of life. The aim of treatment of SLE is to suppress disease activity which is reversible and also to prevent organ damage. SLE affects predominantly women in their reproductive years. The median age of onset in India is 24. 5 4 . This help in formulating the overall treatment plan and in formulating and assessment of prognosis. Anaemia is a common haematological manifestation seen in SLE. Anaemia in SLE may result from several mechanisms and more than one may contribute sometimes. Anaemia of chronic disease is the most common. But it may also be due to auto antibodies to red cells or impaired erythropoietin production by the kidneys. Anaemia may also be due to GI blood loss. Autoimmune haemolytic anaemia is also common in SLE and may be associated with anticardiolipin antibodies, thrombocytopenia, thrombosis often in the context of secondary APLA syndrome [5] [6] [7] . A primary bone marrow involvement leading to hypocellularity, fibrosis and bone marrow necrosis mediated by autoantibodies, immune complexes has also been postulated to be cause for anaemia in SLE 8 .
Materials and Methods
The study was conducted in Department of Medicine, Government Medical College, Trivandrum. This was a hospital based crosssectional study done over a period of 1 year. Sample size was calculated using the formula N=(Z ) 2 
Results

Sex Distribution
Out of 96 patients studied, 87 patients were females and 9 patients were males. 
Figure 1 Sex wise distribution of patients
Age Distribution
Regarding age, 47 patients were below 30 years (49%) followed by 26 patients in the age group 30-39 years (27.1%) and 20 patients were in the age group 40-49(20.8%). 
Fig 3 Anti Sm positivity
Patients with anti Ds DNA positivity All the patients studied were anti Ds DNA positive. 
Peripheral smear findings of patients
As shown in table 5, majority of the patients had normochromic normocytic anemia(77.1%) followed by hypochromic microcytic anemia (16.6%), 6.3% of the patients had dimorphic peripheral smear findings. 
Patients with DCT positive
As shown in fig4,6.3% patients were direct Coombs positive. 
Fig 4 DCT positive
SLE patients with anemia
As shown in fig5, 47 out of 96 patients had anemia (49%). 
Fig 5 Occurrence of anaemia
Types of anemia
The most commonest anaemia observed was anaemia of chronic disease (57.4%) followed by iron deficiency anaemia(21.3%) Anaemia is a common finding in SLE. Anaemia in SLE may result from several mechanisms and more than one may be operative at any time. Out of the 96 patients,87 were females(90.6%) and the rest males(9.4%).
Regarding anaemia of chronic disease in SLE, the pathogenesis remains obscure. (9) , Insufficient supply of hemopoetic cells with EPO along with their resistance to its proliferative action constitutes an important pathogenetic mechanism of anaemia of chronic disease 10, 11 , the presence of autoantibodies against EPO has been proposed as another possible cause of EPO deficiency 12 Iron deficiency anaemia is common in SLE as a result of menorrhagia and increased GI blood loss caused by the use of NSAIDS and oral anticoagulants Antibody induced damage of blood cells has been considered as a pathogenetic mechanism for cytopenias in SLE. Among SLE the prevalence of antiphospholipid antibodies is high ranging from 12% to 30% for anticardiolipin and 15 to 34% for lupus anticoagulant. Several studies in SLE have demonstrated a significant correlation between ACL or Lupus anticoagulant and Coombs positive haemolytic anemia.
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Conclusion
The prevalence of anaemia is very common in SLE. Thus it is one of the most common haematological manifestations of SLE. The causes of anaemia in SLE is multifactorial. Anaemia of chronic disease was the most common type of anaemia in our study. This was followed by Iron deficiency anaemia and haemolytic anaemia.
